Rhoclone 150mg Inj

Rhoclone 150mg Inj is a vital immunological product used to prevent Rh incompatibility-related hemolytic disease of the newborn (HDN). This formulation contains highly purified human immunoglobulin (IgG) specific to the Rh D antigen, which helps prevent the immune system of an Rh-negative mother from producing antibodies against Rh-positive fetal blood cells.

Rh incompatibility occurs when an Rh-negative mother is exposed to Rh-positive fetal red blood cells, which can happen during pregnancy, childbirth, miscarriage, or certain medical procedures. Without intervention, maternal antibodies may attack fetal red blood cells in subsequent pregnancies, leading to severe anemia, jaundice, or even fetal death.

• Anti Rh D Immunoglobulin (150 MCG): Prevents maternal sensitization to Rh-positive red blood cells, ensuring safe future pregnancies.

• Clinical Use: Administered during pregnancy, after childbirth, or following potential Rh-positive fetal blood exposure.

• Safety: Derived from screened human plasma and processed under strict quality controls to minimize risk of infection.

This immunoglobulin is a preventive therapy, not a treatment for established Rh incompatibility, and is considered a standard of care in obstetrics worldwide.